Peptidream Inc. TSE:4587

Initiation of Phase 1 Clinical Trial by Novartis Marks Milestone for PeptiDream

Published August 11, 2026 at 11:30 p.m. UTC

Source: TDnet

Peptidream Inc. (4587) Press Release

View Attachment